Oxygenta Pharmaceutical Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

39.64

30.99

60.52

52.03

13.72

Operating profit

-9.70

-7.12

1.48

3.84

-7.87

Interest

1.59

1.49

0.92

1.78

1.09

Gross profit

-11.25

-8.59

0.56

2.15

-8.93

EPS (Rs)

-1.04

-8.15

-0.43

2.87

-5.67

Other income

0.04

0.02

-

0.09

0.03

Stock adjustment

-1.53

-4.63

4.55

-6.39

0.59

Raw material

35.06

28.13

42.67

43.02

14.99

Power and fuel

-

-

-

-

-

Employee expenses

5.99

1.12

0.33

0.73

0.61

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

9.82

13.49

11.50

10.82

5.40

Provisions made

-

-

-

-

-

Depreciation

2.66

2.05

1.59

1.20

1.00

Taxation

-10.39

0.20

0.12

0.21

-0.15

Net profit / loss

-3.48

-11.57

-0.61

2.93

-5.79

Extra ordinary item

0.04

-0.73

0.55

2.19

3.99

Prior year adjustments

-

-

-

-

-

Equity capital

33.48

14.20

14.20

10.20

10.20

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-24.46

-22.97

2.44

7.39

-57.36

GPM (%)

-28.34

-27.69

.92

4.13

-64.93

NPM (%)

-8.77

-37.32

-1.01

5.62

-42.10